Mirae Asset Global Investments’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$10.2K Buy
4,162
+594
+17% +$1.46K ﹤0.01% 1488
2025
Q1
$27.1K Buy
3,568
+530
+17% +$4.02K ﹤0.01% 1348
2024
Q4
$35.7K Sell
3,038
-254
-8% -$2.99K ﹤0.01% 1321
2024
Q3
$60.8K Buy
3,292
+582
+21% +$10.7K ﹤0.01% 1268
2024
Q2
$58.1K Sell
2,710
-299,122
-99% -$6.41M ﹤0.01% 1217
2024
Q1
$4.91M Buy
301,832
+129,358
+75% +$2.1M 0.01% 901
2023
Q4
$5.17M Sell
172,474
-215,230
-56% -$6.45M 0.01% 884
2023
Q3
$7.94M Buy
387,704
+31,653
+9% +$649K 0.02% 706
2023
Q2
$7.08M Buy
356,051
+51,534
+17% +$1.02M 0.02% 795
2023
Q1
$5.22M Buy
304,517
+20,084
+7% +$344K 0.01% 849
2022
Q4
$5.57M Sell
284,433
-56,963
-17% -$1.11M 0.01% 788
2022
Q3
$5.45M Buy
341,396
+78,396
+30% +$1.25M 0.01% 771
2022
Q2
$3.62M Buy
263,000
+21,808
+9% +$300K 0.01% 939
2022
Q1
$3.83M Sell
241,192
-31,212
-11% -$495K 0.01% 956
2021
Q4
$5.95M Buy
272,404
+62,896
+30% +$1.37M 0.01% 840
2021
Q3
$6.26M Buy
209,508
+43,930
+27% +$1.31M 0.02% 778
2021
Q2
$7.33M Buy
165,578
+29,500
+22% +$1.31M 0.02% 722
2021
Q1
$6.04M Buy
136,078
+73,124
+116% +$3.24M 0.02% 695
2020
Q4
$3.45M Buy
62,954
+13,904
+28% +$762K 0.01% 750
2020
Q3
$1.12M Buy
49,050
+15,824
+48% +$362K 0.01% 932
2020
Q2
$696K Buy
33,226
+13,591
+69% +$285K ﹤0.01% 1028
2020
Q1
$274K Buy
19,635
+2,147
+12% +$30K ﹤0.01% 1219
2019
Q4
$398K Buy
17,488
+3,294
+23% +$75K ﹤0.01% 1293
2019
Q3
$165K Buy
+14,194
New +$165K ﹤0.01% 1389